Nicotine patch vs. nicotine lozenge for smoking cessation: An effectiveness trial coordinated by the Community Clinical Oncology Program

Medicine & Life Sciences

• Tobacco Use Cessation Devices 100%
• Medical Oncology 82%
• Smoking Cessation 70%
• Nicotine 69%
• Smokers 29%
• Logistic Models 15%
• Cognition 9%
• Tobacco Use Disorder 7%
• National Cancer Institute (U.S.) 6%
• Carbon Monoxide 5%
• Psychological Distress 5%
• Therapeutics 5%
• Smoke 5%
• Cues 5%
• Smoking 4%

Chemical Compounds

• Nicotine 86%
• Transdermal 45%
• Smoke 4%
• Carbon Monoxide 3%